TACSTD2 methylation | OR (95% CI) | p-value |
---|---|---|
Metastasis (M0 vs. M1) | 1.18 (1.05–1.35) | 0.008 |
Lymph node status (N0 vs. N1) | 1.21 (1.03–1.43) | 0.021 |
Tumor stage (low vs. high T*) | 1.18 (1.06–1.31) | 0.003 |
Differentiation (low vs. high G**) | 1.16 (1.01–1.34) | 0.033 |
State of Disease (loc vs. adv***) | 1.20 (1.08–1.34) | < 0.001 |